From October 6 to 8, 2026, Epitech Group will meet industry players at CPHI Milano, the International reference event for development and innovation in the pharmaceutical field.
Our presence has twofold objectives: to share the latest progress in the study of Aliamides and consolidate the global collaboration network.
On one hand, this event represents an opportunity to extend the boundaries of our research and promote a pharmacology vision that moves beyond mere symptom suppression toward modulation of endogenous physiological processes. On the other hand, CPHI is the premier setting to meet qualified stakeholders, evaluate out-licensing models, and build joint development synergies with International players.
During the event, our representatives will be available to meet professionals and potential partners to explore how our know-how can be integrated into new health management models.
For a preliminary analysis of collaboration opportunities, please consult the Partnering dedicated page.
